Seres Therapeutics Announces FDA Acceptance of Biologics License Application for Investigational Microbiome Therapeutic SER-109 for Recurrent C. Difficile Infection for Priority Review Read more
WuXi Biologics Announces GMP Release of 48,000L Commercial Drug Substance Manufacturing Facility in Hebei, China Read more
Health Canada approves KERENDIA (finerenone) as an adjunct to standard of care therapy in adults with chronic kidney disease (CKD) and type 2 diabetes (T2D) Read more
Normunity Announces $65 Million Series a Financing to Expand the Frontier of Precision Immuno-Oncology With Immune Normalizer Therapies Read more
FDA Approves TECVAYLI (teclistamab-cqyv), the First Bispecific T-cell Engager Antibody for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Read more
FUJIFILM Diosynth Biotechnologies and RoosterBio Announce Collaboration to enable GMP Manufacturing of Cell and Exosome Therapies Read more
BioMed X Inks Research Collaboration With Sanofi on Artificial Intelligence for Drug Development Read more